Industry Pricing Tactics Are Driving Europe’s Cross-Country Backlash
Norwegian Minister Says Some Drug Prices Are 'Unethical'
Executive Summary
A recent event in Brussels organized by the European Public Health Alliance found that cross-country initiatives on pricing and calls for more R&D and clinical trial transparency are gathering momentum in Europe, but there is still some way to go to address the imbalances in the system. The Pink Sheet spoke to EPHA's Yannis Natsis about the issues raised at the organization's fourth forum on medicines access.